Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells

NCT ID: NCT02617888

Last Updated: 2017-07-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

228 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose

1. To investigate the effects of cardiac imaging radiation on the induction of DNA double-strand breaks by enumerating gamma-H2AX foci in blood lymphocytes and plucked hair follicle cells.
2. To estimate whether the use of breast shields in cardiac computed tomographic angiography (CCTA) limits the effective radiation exposure of breast tissue.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of the study is to analyze blood and hair samples from patients undergoing cardiac imaging to estimate radiation exposure levels as well as their biological effects (i.e. to determine the degree of genotoxicity by measuring the amounts of DNA double-strand breaks).

The secondary objective is to investigate whether the use of in-plane breast shielding in female patients undergoing CT angiography (CCTA) limits the radiation exposure of breast tissue and subsequent DNA damage in blood lymphocytes and hair follicle cells.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Chest Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CCTA Breast Shields

Within female subset, randomization to wearing bismuth breast shield.

Group Type ACTIVE_COMPARATOR

CCTA ~ BREAST SHIELDS

Intervention Type RADIATION

Breast shield placement (randomized) among women.

CCTA No Breast Shields

Within female subset, randomization to wearing no bismuth breast shield (standard of care).

Group Type NO_INTERVENTION

No interventions assigned to this group

Observational Arm

Non-females undergoing CTA and subjects undergoing cardiac catheterization and nuclear medicine testing.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CCTA ~ BREAST SHIELDS

Breast shield placement (randomized) among women.

Intervention Type RADIATION

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BISMUTH BREAST SHIELDS

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult male and female adult subjects (age greater than 18 years)
* Referred for cardiac computed tomography angiography (CCTA), myocardial perfusion scintigraphy (MPS), or diagnostic invasive coronary angiography (ICA).

Exclusion Criteria

* Female patients that identify themselves as pregnant or have a positive pregnancy test prior to cardiac imaging.
* History (present or past) of leukemia or lymphoma.
* History of radiation therapy
* X-ray examination or scintigraphy within the last 72 hours.
* History of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
* Patients undergoing percutaneous coronary intervention at completion of diagnostic left heart catheterization
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Walter Reed National Military Medical Center

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Todd C. Villines

Director of Cardiovascular Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Todd C Villines, MD

Role: PRINCIPAL_INVESTIGATOR

WRNMMC

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

362425

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.